Mayanna Lund Selected Research

factor V Leiden

1/2003

Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mayanna Lund Research Topics

Disease

19	Heart Failure 04/2024 - 11/2016
3	Cardiomyopathies (Cardiomyopathy) 12/2023 - 11/2016
2	Obesity 04/2024 - 01/2021
2	Atrial Fibrillation 04/2024 - 01/2019
1	Chronic Renal Insufficiency 04/2024
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 12/2023
1	Endocarditis 11/2022
1	Death (Near-Death Experience) 01/2021
1	Overweight 01/2021
1	Systolic Heart Failure 01/2021
1	COVID-19 01/2021
1	Acute Coronary Syndrome 09/2020
1	Atrial Flutter (Flutter, Atrial) 01/2019
1	Pathologic Constriction (Stenosis) 01/2003
1	Hemochromatosis (Bronze Diabetes) 01/2003
1	Hypertension (High Blood Pressure) 01/2003
1	Thrombophilia 01/2003

Drug/Important Bio-Agent (IBA)

5	omecamtiv mecarbilIBA 12/2023 - 11/2020
4	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2024 - 11/2020
3	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 01/2021
3	Cardiac MyosinsIBA 01/2021 - 11/2020
2	Natriuretic PeptidesIBA 12/2023 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
1	Neprilysin (Neutral Endopeptidase)IBA 12/2023
1	Penicillins (Penicillin)FDA Link 12/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2023
1	Angiotensin Receptor AntagonistsIBA 01/2023
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	SodiumIBA 01/2022
1	Troponin T (Troponin T1)IBA 01/2022
1	Dietary SodiumIBA 01/2022
1	IronIBA 12/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2020
1	Circulating MicroRNAIBA 01/2019
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2019
1	Amphetamine (Amfetamine)FDA LinkGeneric 11/2016
1	Type 1 Angiotensin ReceptorIBA 01/2003
1	factor V LeidenIBA 01/2003
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2003
1	Endothelial Protein C ReceptorIBA 01/2003
1	Fibrinogen (Factor I)FDA Link 01/2003
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2003
1	Oxidoreductases (Dehydrogenase)IBA 01/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2003
1	Prothrombin (Factor II)IBA 01/2003
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2003
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2003
1	Integrin beta3 (GPIIIa)IBA 01/2003
1	5,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA 01/2003

Therapy/Procedure

7	Therapeutics 02/2024 - 11/2016
1	Drug Therapy (Chemotherapy) 02/2024
1	Diet Therapy (Therapy, Diet) 01/2022
1	Secondary Prevention 09/2020
1	Electric Countershock (Cardioversion) 01/2019